On December 7, 2024, the Union Health Minister Jagat Prakash Nadda launched the ambitious 100-Day TB Elimination Campaign in Panchkula, Haryana, as part of India's ongoing efforts to combat tuberculosis (TB) across the nation. This new campaign targets enhanced TB detection, diagnosis, and treatment across 347 districts in India, with a particular focus on underserved and remote areas. The 100-day initiative aims to significantly reduce the burden of TB and advance India’s goal of eliminating the disease.

The 100-Day TB Elimination Campaign focuses on key strategies to improve the diagnostic capabilities and treatment access for TB patients. A major aspect of this campaign includes the Nikshay Poshan Yojana, a financial assistance scheme that provides nutritional support to TB patients, thereby improving treatment adherence and recovery rates. The Yojana is designed to help families living below the poverty line, particularly in rural and marginalized communities, who may face economic barriers to accessing healthcare.

In addition to expanding diagnostic infrastructure, the campaign aims to provide advanced diagnostic tools and treatment options to those who are most vulnerable. The initiative also seeks to raise awareness about TB, encourage early detection, and reduce the stigma associated with the disease. These efforts are critical to improving the national TB response and achieving India’s goal of eliminating the disease by 2025, a target set by the World Health Organization (WHO).

However, despite the well-laid plans for the 100-Day TB Elimination Campaign, there are growing concerns about drug shortages for TB treatment. Reports indicate that the supply of TB drugs has been inconsistent in certain areas, which could undermine the effectiveness of the campaign. Access to essential medications, such as first-line TB drugs, has been an ongoing issue, and shortages may delay or disrupt the treatment of those who need it most.

These drug shortages are seen as a significant challenge, especially as the government and healthcare providers work to meet the increasing demand for TB treatment services. Without a steady supply of medications, the progress made in improving TB care may be hindered, affecting the outcomes of the 100-day initiative. This issue requires urgent attention from policymakers, health officials, and international organizations to ensure a continuous and reliable supply of TB treatment drugs.

The 100-Day TB Elimination Campaign is a vital step in India’s national effort to control TB and improve the country’s healthcare infrastructure. The initiative is being closely watched by experts and health organizations worldwide, as India carries a significant share of the global TB burden. The success of this campaign is critical to reducing the impact of the disease on public health and advancing the fight against tuberculosis.

The Upcoming IPOs in this week and coming weeks are Dhanlaxmi Corp, Jungle Camps, Toss The Coin, Sai Life Sciences, Mobikwik, Vishal Mega Mart, Supreme Facility, Purple United, Rosmerta Digital, Inventurus Knowledge and Avanse Financial.

The Current active IPO is Emerald Tyre Manufacturers.

For more insights into the latest investment opportunities, upcoming IPOs, and other market news, visit Best IPO to Apply Now - IPO List 2024, Latest IPO, Upcoming IPO, Recent IPO News, Live IPO GMP Today - Finance Saathi and stay updated on the latest share market trends at Top News Headlines - Share Market News, Latest IPO News, Business News, Economy News - Finance Saathi.

Join our Trading with CA Abhay Telegram Channel for regular Stock Market Trading and Investment Calls by CA Abhay Varn - SEBI Registered Research Analyst & Finance Saathi Telegram Channel for Regular Share Market, News & IPO Updates.

Start your Stock Market Journey and apply in IPO by opening a Free Demat Account in Choice Broking FinX.